A top voice in regulating medicines speaks on drug pricing
June 1, 2017
By Tim Silcott – Dr. Scott Gottlieb is a top thought leader when it comes to regulations on medicines and market access. From his view, we see that the issue of drug pricing is extremely complex and will take the entire industry to cooperate. We look forward to seeing Dr. Gottlieb’s take on the issue and how he will be involved in solving the challenge that strikes a balance between profit and patient benefit.
Complex drugs comprise a growing and important portion of our therapeutic armamentarium. Generic entry of important copies of these medicines, once the legitimate IP has lapsed on branded alternatives, has sometimes been needlessly delayed.